Scarica l'app Stockscreener
60.39
0.23%
-0.18
Precedente Chiudi:
$60.57
Aprire:
$60.57
Volume 24 ore:
705.62K
Relative Volume:
0.47
Capitalizzazione di mercato:
$8.16B
Reddito:
$2.51B
Utile/perdita netta:
$185.56M
Rapporto P/E:
45.07
EPS:
1.34
Flusso di cassa netto:
$517.59M
1 W Prestazione:
+1.69%
1M Prestazione:
+7.26%
6M Prestazione:
-28.76%
1 anno Prestazione:
-13.49%
Intervallo 1D:
$60.29
$60.94
Intervallo di 1 settimana:
$59.43
$63.11
Portata 52W:
$51.79
$94.93
Globus Medical Inc Stock (GMED) Company Profile
Nome
Globus Medical Inc
Settore
Industria
Telefono
610-930-1800
Indirizzo
2560 GENERAL ARMISTEAD AVENUE, AUDUBON, PA
Confronta GMED con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GMED
Globus Medical Inc
|
60.40 | 8.18B | 2.51B | 185.56M | 517.59M | 1.34 |
|
ABT
Abbott Laboratories
|
130.40 | 229.31B | 43.11B | 13.94B | 6.78B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.17 | 152.87B | 18.49B | 2.50B | 3.49B | 1.68 |
|
SYK
Stryker Corp
|
381.52 | 146.01B | 23.82B | 2.92B | 4.02B | 7.55 |
|
MDT
Medtronic Plc
|
92.94 | 119.18B | 33.54B | 4.69B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
78.53 | 45.95B | 5.69B | 1.41B | 577.90M | 6.95 |
Globus Medical Inc Stock (GMED) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-27 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-01-10 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-08-07 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-05-20 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2023-10-20 | Iniziato | ROTH MKM | Buy |
| 2023-09-19 | Aggiornamento | Stifel | Hold → Buy |
| 2023-03-30 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2023-02-13 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-02-10 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-02-10 | Downgrade | Loop Capital | Buy → Hold |
| 2023-02-10 | Downgrade | Needham | Buy → Hold |
| 2023-02-10 | Downgrade | Truist | Buy → Hold |
| 2023-02-10 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2022-10-18 | Iniziato | Barclays | Overweight |
| 2022-10-12 | Iniziato | Jefferies | Buy |
| 2022-04-13 | Ripresa | Truist | Buy |
| 2022-03-28 | Iniziato | Wells Fargo | Overweight |
| 2022-01-04 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2021-12-13 | Aggiornamento | BofA Securities | Underperform → Buy |
| 2021-12-10 | Iniziato | RBC Capital Mkts | Outperform |
| 2021-10-29 | Iniziato | Loop Capital | Buy |
| 2021-02-18 | Ripresa | Needham | Buy |
| 2020-12-08 | Iniziato | Citigroup | Buy |
| 2020-10-20 | Iniziato | Stifel | Hold |
| 2020-08-06 | Reiterato | Needham | Buy |
| 2020-08-06 | Aggiornamento | Northland Capital | Market Perform → Outperform |
| 2020-07-21 | Iniziato | Northland Capital | Market Perform |
| 2020-07-06 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2020-05-08 | Reiterato | Needham | Buy |
| 2020-03-18 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2020-01-08 | Iniziato | SunTrust | Buy |
| 2019-12-12 | Aggiornamento | Wells Fargo | Market Perform → Outperform |
| 2019-08-02 | Reiterato | Needham | Buy |
| 2019-05-24 | Downgrade | Wells Fargo | Outperform → Market Perform |
| 2019-05-03 | Reiterato | Needham | Buy |
| 2019-02-28 | Aggiornamento | UBS | Neutral → Buy |
| 2019-01-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-06-27 | Downgrade | BofA/Merrill | Neutral → Underperform |
| 2018-06-01 | Iniziato | Cantor Fitzgerald | Overweight |
| 2018-05-03 | Reiterato | Needham | Buy |
| 2018-04-04 | Aggiornamento | Needham | Hold → Buy |
Mostra tutto
Globus Medical Inc Borsa (GMED) Ultime notizie
Globus Medical Inc. Outperforms Peers on Volume MetricsTrade Analysis Summary & Precise Swing Trade Alerts - sundaytimes.kr
Is Globus Medical Inc. a defensive stockJuly 2025 Outlook & Proven Capital Preservation Tips - sundaytimes.kr
Globus Medical Inc. Building a Base Near SupportWeekly Trade Report & Weekly Momentum Stock Picks - newsyoung.net
Is Globus Medical Inc. a turnaround storyChart Signals & Risk Controlled Stock Pick Alerts - sundaytimes.kr
Globus Medical (GMED): A High-Quality Growth Story with Strong Earnings and Strategic Momentum - AInvest
Globus Medical's (NYSE:GMED) Strong Earnings Are Of Good Quality - Yahoo Finance
Globus Medical to Announce Q2 2025 Financial Results on August 7, Followed by Investor Call - MSN
Globus Medical Inc. Ranks High in Smart Money TrackerJuly 2025 Earnings & Intraday High Probability Alerts - newsyoung.net
Globus Medical Sees Robust Growth Amidst Challenges: Key Takeaways from Q2 Earnings Call. - AInvest
Orthobiologics Market to Experience Massive Growth by 2032 - openPR.com
Globus Medical’s Q2 Earnings Call: Our Top 5 Analyst Questions - Yahoo Finance
2 Healthcare Stocks to Consider Right Now and 1 We Find Risky - FinancialContent
Globus Medical Stock Up on Q2 Earnings & Revenue Beat, Margins Expand - Nasdaq
UFP Technologies, Inspire Medical Systems, Globus Medical, Neogen, and Dentsply Sirona stocks soar on positive inflation data, Fed rate cut hopes. - AInvest
Inspire Medical Systems, UFP Technologies, Globus Medical, Neogen, and Dentsply Sirona Shares Skyrocket, What You Need To Know - TradingView
Globus Medical (GMED) Receives Hold Rating from Truist Financial and Needham, Upgrade to Buy from TR | OpenAI – 4o - AInvest
Globus Medical, Inc. (NYSE:GMED) Q2 2025 Earnings Call Transcript - Insider Monkey
Globus Medical (GMED) Receives a Hold from Truist Financial - The Globe and Mail
Quant Strategy Flags Globus Medical Inc. for EntryWeekly Chart Analysis With Entry Advice Provided - beatles.ru
Globus Medical, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions - 富途牛牛
Globus Medical Delivers Strong Q2 Results, Reaffirms 2025 Outlook - MSN
A Quick Look at Today's Ratings for Globus Medical(GMED.US), With a Forecast Between $66 to $106 - 富途牛牛
Are Investors Undervaluing Globus Medical, Inc. (NYSE:GMED) By 43%? - Yahoo Finance
RBC Capital Sticks to Its Buy Rating for Globus Medical (GMED) - The Globe and Mail
Globus Medical's Q2 2025 Earnings and Strategic Leadership Shifts: A Blueprint for Sustained Growth - AInvest
Globus Medical Surges 8.47% on $210M Volume as Q2 Sales Hit $745M Propelling It into Top 500 High-Volume Stocks - AInvest
Globus Medical: A Strategic Powerhouse in the Evolving Spine Care Landscape - AInvest
Globus Medical reaffirms $2.8B–$2.9B 2025 sales outlook as integration advances and U.S. Spine momentum builds - MSN
Globus Medical Reiterates $2.8B-$2.9B 2025 Sales Outlook Amid Integration Progress and Growing US Spine Market - AInvest
Globus Medical (GMED) Stock Rises on Better-Than-Expected Q2 ResultsNews and Statistics - IndexBox
How Globus Medical's (GMED) Surge in Net Income and Sales May Reshape Its 2025 Outlook - simplywall.st
Barclays raises Globus Medical stock price target to $106 on margin strength - Investing.com Canada
Globus Medical 2025 Q2 Earnings Record Net Income Surges 538.7% - AInvest
Globus Medical (GMED) Shares Skyrocket, What You Need To Know - TradingView
Transcript : Globus Medical, Inc., Q2 2025 Earnings Call, Aug 07, 2025 - MarketScreener
Globus Medical worldwide sales up 18.4% to USD 745.3M in Q2 2025 - Medical Buyer
Globus Medical (NYSE:GMED) Exceeds Q2 Expectations - TradingView
Globus Medical shares rise 6.90% premarket after Q2 sales, adjusted EPS beat expectations. - AInvest
Globus Medical Inc (GMED) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada
Globus Medical: Q2 Earnings Snapshot - Greenwich Time
Globus Medical Reports Strong Q2 2025 Growth - TipRanks
Globus Medical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Decoding Globus Medical Inc (GMED): A Strategic SWOT Insight - GuruFocus
Globus Medical Q2 Earnings Top Consensus, Revenue Hits $745.3M - AInvest
Globus Medical Outperforms Expectations With Strong Q2 Results - Finimize
Globus Medical's Q2 2025 Earnings Outperformance: A Masterclass in Operational Execution and Strategic Innovation - AInvest
Globus Medical (GMED) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo Finance
Globus Medical earnings beat by $0.10, revenue topped estimates - Investing.com Canada
Globus Medical (GMED) Q2 Revenue Up 18% - AOL.com
Globus Medical (GMED) Beats Q2 Earnings and Revenue Estimates - Yahoo Finance
Globus Medical Q2 sales, adjusted EPS beat expectations - MarketScreener
Globus Medical Inc Azioni (GMED) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.07%
0.39%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):